PAC - did you disremember 2018 was the year Anteo shed itself the Dudasource M&A. Figures from that period are unrelated. Oranges/Lemons - whatever when there is an agenda to run! Hey it's your opinion, but best stick to relatable Facts if you're going to attempt to compare.
Scientists are the hub of Anteo works - and will be into the future - paying lab rats (& granting performance options) is an industry norm - they may love their work but folk deserve to be compensated. As a SH you're in for the ride. Invest or don't its up to you, and any risk is yours. Funny how folk never complain when a once a company returns.
As for Rights & Oppies turnover - someone is selling - and is the way - someone is buying. At this stage of Company (re-) development, the lower the SP the less risk.
